JUBLINGREA: Q2 EBITDA surged 51% YoY as all three segments grew; ZettaOne expands the semiconductor platform

What happened

Jubilant Ingrevia's Q2 revenue rose 24% year over year to ₹1,394 crore and EBITDA, a measure of operating profit, grew 51% to ₹221 crore, with all three segments growing. A ₹189.2 crore cash investment secured a 40% stake in ZettaOne.

Confirmed

Global impact / market context

Faster profit growth than revenue growth suggests the company kept a larger share of each sale, which means better profit per sale. The ZettaOne stake adds a semiconductor-related business, giving the company a new area for future revenue and capital spending beyond its current segments.

Analyst inference

The results show broad-based growth across all three segments, not one strong division hiding weaker ones. The cash-funded ZettaOne purchase uses money the company already holds rather than borrowed money, which limits added financial risk while expanding the business platform.

Analyst inference

What to watch

1. The company expects growth across segments in FY27, so investors will watch whether each of the three segments keeps growing or whether growth becomes concentrated in fewer areas. Confirmed
2. Track how the 40% ZettaOne stake is used, including any further cash outlays, partnership steps, or semiconductor-related plans that could change the company's capital spending priorities. Proposed
3. Watch whether EBITDA continues growing faster than revenue, since that pattern would show the company is preserving profit per sale, while a reversal would suggest rising costs are pressuring results. Analyst inference

Evidence

• Original source link unavailable